In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Novartis licenses rights to Proteus' IP to develop drugs

Executive Summary

Novartis has licensed exclusive global rights to develop and market organ transplant drugs that incorporate Proteus Biomedical's (micro-electromechanical systems for congestive heart failure) sensor-based technologies.
Deal Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Medical Devices
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register